Simultaneous Runs of the Bayer VERSANT HIV-1 Version 3.0 and HCV bDNA Version 3.0 Quantitative Assays on the System 340 Platform Provide Reliable Quantitation and Improved Work Flow

Branched DNA (bDNA) assays to quantify human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) consist of three distinct steps, including sample processing, hybridization, and detection, and utilize the System 340 platform for plate incubation and washing. Sample processing differs:...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Elbeik, Tarek, Markowitz, Norman, Nassos, Patricia, Kumar, Uday, Beringer, Scott, Haller, Barbara, Ng, Valerie
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2004
Assuntos:
Virology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC446273/
https://ncbi.nlm.nih.gov/pubmed/15243070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.42.7.3120-3127.2004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares